Azithromycin in the treatment of pneumonia caused by Chlamydia pneumoniae: Report of a case

J. H. Wang; J. H. Wang; Y. C. Liu; Y. S. Chen; M. Y. Yen; S. R. Wann; D. L. Cheng

Azithromycin in the treatment of pneumonia caused by Chlamydia pneumoniae: Report of a case

J. H. Wang, J. H. Wang, Y. C. Liu, Y. S. Chen, M. Y. Yen, S. R. Wann, D. L. Cheng

研究成果: 雜誌貢獻 › 文章 › 同行評審

摘要

We report a 67-year-old male with pneumoniae in which Chlamydia pneumoniae was identified by serologic studies as the causative agent. After initial treatment failure with amoxicillin + clavulanic acid, pneumonia was successfully treated with the administration or oral azithromycin, 500 mg per day, for three days. Azithromycin is a new macrolide which has a long half-life and superior action to erythromcyin. It provides a new and alternative choice in the treatment of Chlamydia pneumoniae infection in the future.

原文	英語
頁（從 - 到）	642-644
頁數	3
期刊	Journal of the Formosan Medical Association
卷	93
發行號	7
出版狀態	已發佈 - 1994
對外發佈	是

ASJC Scopus subject areas

醫藥 (全部)

其它文件與鏈接

Link to publication in Scopus

引用此

@article{59bb0335d46b434ebab2c1a5926accb7,

title = "Azithromycin in the treatment of pneumonia caused by Chlamydia pneumoniae: Report of a case",

abstract = "We report a 67-year-old male with pneumoniae in which Chlamydia pneumoniae was identified by serologic studies as the causative agent. After initial treatment failure with amoxicillin + clavulanic acid, pneumonia was successfully treated with the administration or oral azithromycin, 500 mg per day, for three days. Azithromycin is a new macrolide which has a long half-life and superior action to erythromcyin. It provides a new and alternative choice in the treatment of Chlamydia pneumoniae infection in the future.",

keywords = "Chlamydia pneumoniae, azithromycin",

author = "Wang, {J. H.} and Wang, {J. H.} and Liu, {Y. C.} and Chen, {Y. S.} and Yen, {M. Y.} and Wann, {S. R.} and Cheng, {D. L.}",

year = "1994",

language = "English",

volume = "93",

pages = "642--644",

journal = "Journal of the Formosan Medical Association",

issn = "0929-6646",

publisher = "Elsevier Science Publishers B.V.",

number = "7",

}

TY - JOUR

T1 - Azithromycin in the treatment of pneumonia caused by Chlamydia pneumoniae

T2 - Report of a case

AU - Wang, J. H.

AU - Liu, Y. C.

AU - Chen, Y. S.

AU - Yen, M. Y.

AU - Wann, S. R.

AU - Cheng, D. L.

PY - 1994

Y1 - 1994

N2 - We report a 67-year-old male with pneumoniae in which Chlamydia pneumoniae was identified by serologic studies as the causative agent. After initial treatment failure with amoxicillin + clavulanic acid, pneumonia was successfully treated with the administration or oral azithromycin, 500 mg per day, for three days. Azithromycin is a new macrolide which has a long half-life and superior action to erythromcyin. It provides a new and alternative choice in the treatment of Chlamydia pneumoniae infection in the future.

AB - We report a 67-year-old male with pneumoniae in which Chlamydia pneumoniae was identified by serologic studies as the causative agent. After initial treatment failure with amoxicillin + clavulanic acid, pneumonia was successfully treated with the administration or oral azithromycin, 500 mg per day, for three days. Azithromycin is a new macrolide which has a long half-life and superior action to erythromcyin. It provides a new and alternative choice in the treatment of Chlamydia pneumoniae infection in the future.

KW - Chlamydia pneumoniae

KW - azithromycin

UR - http://www.scopus.com/inward/record.url?scp=0028598698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028598698&partnerID=8YFLogxK

M3 - Article

C2 - 7866068

AN - SCOPUS:0028598698

SN - 0929-6646

VL - 93

SP - 642

EP - 644

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

IS - 7

ER -

Azithromycin in the treatment of pneumonia caused by Chlamydia pneumoniae: Report of a case

摘要

ASJC Scopus subject areas

其它文件與鏈接

指紋

引用此